| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/14/1994 | EP0511221B1 Process for enriching or cleaning hirudin |
| 09/14/1994 | EP0494873B1 Method for recovering recombinant proteins using flocculating agents |
| 09/14/1994 | EP0485525B1 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 09/14/1994 | EP0403591B1 Crf analogs |
| 09/14/1994 | EP0162078B1 Method for isolating a protein from a mixture containing said protein and a conformation specific antibody useful therein |
| 09/14/1994 | CN1092071A Spiro piperidines and homologs which promote release of growth hormone |
| 09/13/1994 | US5346998 Artificial |
| 09/13/1994 | US5346993 Isolated, large latent complexes of TGF-β2 and TGF-β3, and new binding protein for latent form TGF-β1, TGF-β2 and TGF-β3 LTBP-2 |
| 09/13/1994 | US5346992 Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction |
| 09/13/1994 | US5346991 Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
| 09/13/1994 | US5346990 Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 09/13/1994 | US5346989 Peptides for use in induction of T cell activation against HIV-1 |
| 09/13/1994 | US5346988 Process for obtaining cellular protein having anti-HIV activity |
| 09/13/1994 | US5346815 Sodium ion binding proteins |
| 09/13/1994 | US5346696 Recombinent Interferon |
| 09/13/1994 | US5346687 Partial reduction of disulfide bonds with stannous compound |
| 09/11/1994 | CA2118642A1 Bone-associated transcription control factor-like protein and process for producing the same |
| 09/10/1994 | CA2118558A1 Soluble human fc-gamma iii receptors, process for the preparation thereof, pharmaceutical compositions containing same, utilization thereof as medicaments, and diagnostic application thereof |
| 09/07/1994 | EP0613947A2 Mitogenic factor, gene thereof and method of microdetection therefor |
| 09/07/1994 | EP0613946A2 hst-2 Mutein, DNA coding for the same and preparation thereof |
| 09/07/1994 | EP0613945A2 Tumor suppressor gene merlin and uses thereof |
| 09/07/1994 | EP0613944A2 Methods for regulating the immune response using CTLA4-binding molecules and IL4-binding molecules |
| 09/07/1994 | EP0613904A2 Vasoactive intestinal peptide analogs for treating smooth muscle disorders and/or asthma |
| 09/07/1994 | EP0613880A1 Agent and method for the immunological determination of Diphenhydramine and its metabolites |
| 09/07/1994 | EP0613500A1 Membrane expression of heterologous genes |
| 09/07/1994 | EP0613499A1 Human il-4 mutant proteins |
| 09/07/1994 | EP0613498A1 Receptor derivates with binding sites for human rhinoviruses |
| 09/07/1994 | EP0613497A1 Lymphoid cd30-antigen. |
| 09/07/1994 | EP0613496A1 Collagen-like polypeptides |
| 09/07/1994 | EP0613495A1 Transgenic animals lacking prion proteins |
| 09/07/1994 | EP0613484A1 Bactericidal product, pharmaceutical composition containing same and food additive |
| 09/07/1994 | EP0613378A1 Induction of protection against viral infection by synergy between viral proteins and viral peptides |
| 09/07/1994 | EP0613375A1 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 09/07/1994 | EP0462210B1 Vaccines for nontypable haemophilus influenzae |
| 09/07/1994 | EP0411033B1 Storage stable formulations of homogenous dimeric m-csf |
| 09/07/1994 | CN1091775A Marmoset zona pellucida protein ZP3 |
| 09/07/1994 | CN1091773A Recombinant mutant pastaurella multocida protein, process for preparing same, DNA sequence encoding the protein, replicon comprising the DNA sequence and cells transformed with such replicon |
| 09/07/1994 | CN1091746A Synthetic peptides derived from vitronectin and pharmaceutical compositions them |
| 09/07/1994 | CN1025860C Cross reactive and protective epitope of cicumsporozoite proteins |
| 09/06/1994 | US5344920 Method of separating glycosylated and non-glycosylated prolactin by ion exchange chromatography |
| 09/06/1994 | US5344919 Heterodimeric protein complex; pancreatic cancer diagnosis |
| 09/06/1994 | US5344918 Process for the manufacture of a high-purity activated factor VII concentrate essentially free of vitamin K-dependent factors and factors VIIIC and VIIICAg |
| 09/06/1994 | US5344915 Proteins and the preparation thereof |
| 09/06/1994 | US5344913 Biodegradable; high strength detergent |
| 09/06/1994 | US5344833 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 09/06/1994 | US5344822 Methods useful in endotoxin prophylaxis and therapy |
| 09/06/1994 | US5344821 Insecticides |
| 09/06/1994 | US5344820 Infection protectant |
| 09/06/1994 | US5344819 Pharmaceutical compositions for use in treating inflammation |
| 09/06/1994 | US5344783 Platelet aggregation inhibitors |
| 09/06/1994 | US5344776 DNA encoding an insect octopamine receptor |
| 09/06/1994 | US5344774 Human intracisternal A-type retroviral particles associated with sjogren's syndrome |
| 09/06/1994 | US5344773 Human uterine tissue plasminogen activator produced by recombinant DNA |
| 09/06/1994 | US5344771 Plant thiosterases |
| 09/06/1994 | US5344765 Cercropin |
| 09/06/1994 | US5344764 Protein inhibitors of phospholipase A2 purified from inflammatory sites and production process |
| 09/06/1994 | US5344760 Analysis of epidermal growth factor |
| 09/06/1994 | US5344654 Protein coating |
| 09/06/1994 | US5344645 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/06/1994 | CA2116280A1 Huntingtin dna, protein and uses thereof |
| 09/06/1994 | CA2114168A1 Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
| 09/04/1994 | CA2090879A1 Targets for the prevention and cure of female breast cancer: bc534 and bc538, two reconstructed cdnas and encoded proteins antisense to the human tumour antigen p53 gene |
| 09/01/1994 | WO1994019697A1 Methods of inducing immunity to lyme disease and a colorimetric assay for borreliacidal activity of antisera |
| 09/01/1994 | WO1994019692A1 Alzheimer's disease therapeutics |
| 09/01/1994 | WO1994019495A1 Recombinant epstein-barr viral capsid antigen useful in diagnostic method |
| 09/01/1994 | WO1994019494A1 Inhibition of tax-mediated increase in dna binding |
| 09/01/1994 | WO1994019493A1 Compounds and methods for the diagnosis, treatment and prevention of diseases of cell death |
| 09/01/1994 | WO1994019485A1 A method for detecting compounds with growth hormone and growth hormone receptor activity |
| 09/01/1994 | WO1994019482A1 Heterologous antigens in live cell vaccine strains |
| 09/01/1994 | WO1994019475A2 Yeast agglutination genes and yeast containing them |
| 09/01/1994 | WO1994019474A1 Process for producing human growth hormone |
| 09/01/1994 | WO1994019473A1 Modulators of gene expression |
| 09/01/1994 | WO1994019470A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases |
| 09/01/1994 | WO1994019469A1 Multi-vip fusion protein and method of preparing recombinant vip |
| 09/01/1994 | WO1994019467A1 Brazzein sweetener |
| 09/01/1994 | WO1994019465A2 NOVEL DNA- BINDING REGULATOR OF c-myc EXPRESSION WHICH BINDS TO THE FAR UPSTREAM ELEMENTS (FUSE) AND cDNA THEREFOR |
| 09/01/1994 | WO1994019464A2 Human dna sequence encoding a kidney atp-dependent potassium channel |
| 09/01/1994 | WO1994019463A2 Developmental tyrosine kinases and their ligands |
| 09/01/1994 | WO1994019462A1 Harp family growth factors, preparation methods therefor and uses thereof |
| 09/01/1994 | WO1994019461A1 METHOD FOR IDENTIFYING COMPOUNDS THAT INDUCE AN INCREASED LEVEL OF THE NERVE GROWTH FACTOR mRNA |
| 09/01/1994 | WO1994019459A1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
| 09/01/1994 | WO1994019456A1 Vpr function and activity |
| 09/01/1994 | WO1994019375A1 Iron-lactoferrin combination and process for producing the same |
| 09/01/1994 | WO1994019374A1 IgM-SPECIFIC RECOMBINANT RHEUMATOID ARTHRITIS ANTIGEN |
| 09/01/1994 | WO1994019373A1 Metal-interferon-alpha crystals |
| 09/01/1994 | WO1994019024A2 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING |
| 09/01/1994 | WO1994019021A1 Protein conjugates, compositions containing them and their applications as medicament |
| 09/01/1994 | WO1994019017A1 Synergistic composition of cd4-based protein and anti-hiv-1 antibody, and methods of using same |
| 09/01/1994 | WO1994019015A1 Recombinant fowlpox viruses and uses thereof |
| 09/01/1994 | WO1994019014A1 Recombinant fowlpox virus s-fpv-043 and uses thereof |
| 09/01/1994 | WO1994019011A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 09/01/1994 | WO1994019009A1 Methods for modifying the t cell repertoire of the immune system |
| 09/01/1994 | WO1994019007A1 Ribosome inactivating protein compositions having reduced antigenicity |
| 09/01/1994 | WO1994019004A1 Ligand antagonists for treatment of breast cancer |
| 09/01/1994 | WO1994019002A1 Regulator regions of g proteins |
| 09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
| 09/01/1994 | WO1994018998A1 Treatment of allergic responses using mhc-peptide complexes |
| 09/01/1994 | WO1994018996A1 Method for administering growth hormone releasing peptides |
| 09/01/1994 | WO1994018995A1 Allogeneic vaccine and method to synthesize same |
| 09/01/1994 | WO1994018959A1 Calcium receptor-active molecules |